About the author
Lynn
M. Westphal MD
Associate Professor -Med Center Line
Stanford University School of Medicine
Department of OB/GYN
300 Pasteur Drive, HH-333
Stanford, CA 94305-5317
Tel: 650-498-7317
Education
1979 - 1983 - Lawrence University B.A., Summa cum laude, Interdisciplinary Sciences
1983 - 1987 - Stanford University School of Medicine M.D., 1987
Postgraduate Medical Training
1987 - 1989 University of California, Los Angeles Obstetrics and Gynecology, PGY-1, 2
1989 - 1990 Stanford University Gynecology and Obstetrics, PGY-3
1990 - 1991 Stanford University Gynecology and Obstetrics, PGY-4 Administrative Chief Resident
1992-1993 Stanford University Division of Endocrinology Fellowship in Molecular Biology
1993-1995 University of California, San Francisco Fellowship in Reproductive Endocrinology and Infertility
Professional Experience
1991-1993 Clinical Instructor - Department of Gynecology and Obstetrics, Stanford University
1992-1993 Faculty, Stanford Endoscopy Center for Training and Technology
1995- 1998 Director and Founder, Peninsula Fertility
Clinical Assistant Professor, Voluntary Clinical Faculty, Stanford
University
1998- Director, Ovum Donation and Fertility Preservation Programs
1998-2005 Assistant Professor, Division of Reproductive Endocrinology and Infertility, Department of Gynecology and Obstetrics, Stanford University
2003-2005 Associate Director, Reproductive Endocrinology and Infertility Fellowship, Stanford
2005- Associate Professor, Division of Reproductive Endocrinology and Infertility, Department of Gynecology and Obstetrics, Stanford University
2005- Director, Women’s Health at Stanford
Director, Reproductive Endocrinology and Infertility Laboratory
2005- Acting Director, Reproductive Endocrinology and Infertility Fellowship, Stanford
2005- Acting Chief, Division of Reproductive Endocrinology and Infertility
Board Certification
American Board of Obstetrics and Gynecology, certified 1994 with yearly recertification
Reproductive Endocrinology and Infertility, certified 1997 with yearly recertification
Licensure
California
Awards and Honors
1979 Valedictorian, Forest View High School
1979 National Merit Scholar
1982 Phi Beta Kappa
1983 Summa cum laude
1983 Peerenboom Prize Scholarship in the Field of Semantics
1994 ACOG-Mead Johnson Fellowship
2004 AcademicKeys Who's Who in Medical Sciences Education
2004 Listed in Guide to America’s Top Obstetricians and Gynecologists, 2004-2005
2005 Telly Award given to program on Preserving Fertility in Cancer Patients, (premier award honoring outstanding local, regional and cable TV commercials and programs)
Memberships and Activities
American College of Obstetricians and Gynecologists
American Society for Reproductive Medicine
Society for Reproductive Endocrinology and Infertility
Bay Area Reproductive Endocrinology Society
Pacific Coast Reproductive Society
Ad hoc Reviewer
Human Reproduction
Fertility and Sterility
Journal of Adolescent Health
Journal of Reproductive Medicine
Committees
Stanford University and Hospital:
1998-present GYN/OB Residency Selection
1998-present REI Fellowship Selection
2000-2001 Utilization Management
2002 Care Management Committee
2002-present Ethics Committee
2002 REI/CWHRM Search Committee Member
2005- Stanford Human Embryonic Stem Cell Advisory
Committee
2005 Cancer Care Committee
2005 OB/GYN CME Committee
2006 CVI Women's Cardiovascular Health Working Group
2006 Chair, REI/MCL Search Committee
Regional and National:
2002 Abstract Committee, ASRM Meeting
2004 Program Committee, Pacific Coast Reproductive
Society Meeting
2004–2005 Nominating Committee, Society for
Reproductive Endocrinology and Infertility
2004-2005 Executive Board, Membership Chair, Pacific
Coast Reproductive
Society
2005-2006 Program Committee, Chair, Pacific Coast
Reproductive Society, 2006 meeting
2005- Membership Committee, SART
Invited Lectures
April, 1996 Recent Advances in Infertility Treatment - Grand Rounds,
Seton Medical Center, Dept. OB/GYN
January, 1998 Androgenic Syndromes - Grand Rounds, Santa Clara County
Medical Center, Dept. OB/GYN
September, 1998 Oocyte Donation - Grand Rounds, Stanford University
Medical Center, Dept. GYN/OB
March, 2000 Randomized Trials of Laparoscopy - Monte Carlo Conference on
Updates in Gynecology, Monaco
May, 2000 Be Fruitful and Multiply: A discussion of assisted
reproductive technology and Jewish law - 18th Annual Maimonides Society
Dinner, Burlingame, California
October, 2000 Oocyte Donation - Round Table presentation at the American
Society for Reproductive Medicine, San Diego, California.
October, 2000 Ovulation induction with clomiphene citrate - New Concepts
in Reproductive Endocrinology and Infertility Conference, Oakland,
California.
February, 2001 Reproductive Health and Fertility - Stanford University
Graduate School of Business, Stanford, California.
April, 2001 Fertility Options for Cancer Patients - BMT service,
Stanford, California
September, 2001 Infertility Evaluation - New Nurse Preceptorship
Program, Stanford, California
October, 2001 Oocyte Donation - Round Table presentation at the American
Society for Reproductive Medicine, Orlando, Florida
March, 2002 Translational Medicine: Oocyte Cryopreservation - Grand
Rounds, Stanford University Medical Center, Dept. GYN/OB
May, 2002 Bioethics and Reproductive Medicine - Center for Bioethics,
Stanford, CA
September, 2002 Female Infertility - New Nurse Preceptorship Program,
Stanford, California
November, 2002 Infertility for the Family Practitioner - Dept. Family
Practice, Stanford University
November, 2002 Fertility Options for Cancer Patients - Innovations and
Controversies in Fertility Conference, Stanford, CA
May, 2003 Fertility Preservation in Cancer Patients - UCLA/Harbor
Obstetrics and Gynecology Collegium, Los Angeles, CA
September 2003 Fertility Options for Cancer Patients - New Nurse
Preceptorship Program, Stanford, California
October 2003 PMS- has anything changed? - Round Table presentation at
the American Society for Reproductive Medicine, San Antonio, Texas
November 2003 Fertility Preservation - Resident Teaching Rounds, Dept.
OB/GYN, Stanford University
December 2003 Fertility Options and Quality of Life - Ovum Donation and
Beyond Symposium, New York, New York (Scientific chair of meeting)
April 2004 Fertility Preservation for Cancer Patients - Round Table
presentation at Pacific Coast Reproductive Society, Rancho Mirage,
California
September 2004 Oocyte Cryopreservation and Fertility Preservation - New
Nurse Preceptorship Program, Stanford, California
October 2004 Fertility Options for Cancer Survivors - Round Table
presentation at the American Society for Reproductive Medicine,
Philadelphia, PA
November 2004 Options for Fertility Preservation in Women - IVF
Clinical Practice Update, Stanford, California
February 2005 What every oncologist should know about fertility
preservation -Cancer education Seminar Series, Stanford, California
March 2005 Fertility Preservation for Cancer Survivors - San Francisco
OB/GYN Society, San Francisco, California
March 2005 Updates in Infertility: Fertility Preservation for cancer
survivors - Endocrine Rounds, Stanford, California
March 2005 Fertility preservation for oncologists - Hematology seminar,
Stanford, California
May 2005 Parenthood after cancer - Oncology Nursing Society, Orlando, FL
May 2005 Fertility Preservation - Pediatric Endocrinology Journal Club,
Stanford, California
June 2005 Fertility Options for Premature Ovarian Failure - Endocrine
Society Meeting, San Diego, California
June 2005 Ovum Donation Process - Frontiers in Human Embryonic Stem
Cells Training Course, Stanford, California
November 2005 Oocyte Cryopreservation and Fertility Preservation - New
Nurse Preceptorship Program, Stanford, California
January 2006 Infertility Update - El Camino Hospital Grand Rounds,
Mountain View, California
February 2006 Fertility Preservation - Pediatric Grand Rounds, Stanford,
California
February 2006 Fertility Preservation for Breast Cancer Survivors - 6th
Annual Conference for Young Women Affected by Breast Cancer, Denver,
Colorado
March 2006 Fertility Issues in the Obese Woman - Morbid Obesity
Conference, Stanford, California
March 2006 Fertility Preservation - Grand Rounds, El Camino Hospital,
Mountain View, California
May 2006 Cancer Treatment and Reproductive Potential Midwest
Reproductive Symposium, Chicago, Illinois
Community Education
June 1997 Infertility. Resolve Symposium, Oakland, California
February 1998 Age related infertility. Women’s Health Forum. Mountain
View, California
June 1998 Infertility and oocyte donation. Resolve Symposium, Oakland,
California
March 2000 The Learning Channel, NYT Television: “Maternity Ward”,
episode #2: Hard Labor”.
May 2000 Oocyte Donation. Resolve Symposium, Marin, California
January 2001 Secondary Infertility. Resolve Symposium, Palo Alto,
California
June 2002 Fertility Options for Cancer Patients. Secondary Infertility.
Resolve Symposium, Oakland, California
September 2002 Fertility and Nutrition. Discussion sponsored by
Pregnancy.org
October 2002 Oocyte Donation. Resolve Symposium. Los Gatos, California
November 2002 Fertility Issues after Breast Cancer. Fertile Hope/Y-Me
teleconference
July 2003 Fertile Hope for Cancer Patients, Resolve teleconference
October 2003 Fertility and the Safety of Pregnancy after Breast Cancer,
Living Beyond Breast Cancer teleconference.
May 2004 Fertility after breast cancer. Breast Cancer Community Project,
Palo Alto, California.
May 2004 Fertility options for cancer survivors. Women’s Health at
Stanford Symposium, Stanford, California
May 2004 Fertility Preservation. McKinsey Alumnae Association, San
Francisco, California
July 2004 Current Issues and Updates Regarding Assisted Reproductive
Technologies, Resolve Focus Workshop, San Francisco, California
September 2004 Preserving Fertility in Cancer Patients. Stanford
University Cancer Center
October 2004 Preserving Fertility in Cancer Patients, Stanford Health
Library (recipient of Telly award)
October 2004 Parenthood after Breast Cancer. Young Survival
Coalition/Fertile Hope teleconference
March 2005 4th Annual Allison Taylor Holbrooks Breast Cancer Conference,
San Francisco, California
April 2005 Egg freezing update. Extend Fertility teleconference.
Grant Support (Active)
Ferring. Aromatase inhibitors for IVF poor responders. (PI, July 2004-July 2006, $19,000)
Genesis grant. PGD as a tool to lower multiple gestation rate. (PI, August 2004-August 2005, $29, 500)
Serono. Egg freezing in ovum donors. (PI, August 2005-August 2006, $50,000)
Wyeth. A double-blind, randomized, placebo- and active-controlled
safety and efficacy study of bazedoxifene/conjugated estrogens
combinations in postmenopausal women. (PI, August 2005-January 2006).
Grant Support (Completed)
Daily Wellness Company. “A Double-Blind Placebo-controlled Trial of
Fertility Blend, A Nutritional Supplement, in the Reproductive Health of
Women and Men.” (PI, March 2002-March 2005, $44,000)
Breast Cancer Research Program. “Chemotherapy induced ovarian damage:
prevention and impact.” (Co-PI, July 2002-June 2004, $82,886)
Genesis grant. “Preimplantation Genetic Diagnosis (PGD) as both a
diagnostic and therapeutic tool in assisted reproductive technology
(ART)”
(PI, March 2004-March 2005, $29,500)
Serono “A quality of life survey regarding use of autoinjector for
infertility treatment.” Principal Investigator 2002.
Organon, Protocol 142-001 “An open-label, non-controlled multi-center
study to evaluate subject comprehension, ease of use, safety and
efficacy of the Follistim Pen for the self-administration of
Follistim-AQ during controlled ovarian hyperstimulation (COH) subjects
scheduled for IVF or ICSI.” Principal Investigator, 2002
Serono, Protocol 21750: "A phase III, multicenter, double-blind,
randomized, parallel group study to compare the safety and efficacy of
recombinant human luteinizing hormone with urinary human chorionic
gonadotropin in inducing final follicular maturation and early
luteinization in infertile women undergoing ovarian stimulation with
recombinant human follicle stimulating hormone prior to IVF-ET"
Principal Investigator 2000-2001
Ferring Pharmaceuticals Inc., Protocol FPI-FSH-2000-05 "A randomized,
comparative, 3-arm, parallel group, open-label, multicenter study of the
efficacy and safety of purified human FSH (hFHS) SC and Repronex SC when
combined in continuous or sequential dose ratios in female patients
34-40 years of age, undergoing In-Vitro Fertilization (IVF). Principal
Investigator 2001
ACOG-Mead Johnson Clinical Research Fellowship 1994-1995
Postmenopausal Estrogen/Progestin Interventions Trial. National
Institute of Health #HL25562 Participating Investigator 1991-1993
Laser-assisted micromanipulation of gametes Office of Naval Research,
Medical Free Electron Laser Program. Co-principal Investigator 1992-1993
Teaching courses
OB/GYN residency training (1991- present)
REI fellowship training (1995-present)
Medical student clinical and early preclinical rotations (1995-present)
Stanford Shadow Mentor Program for undergraduates (2003-present)
GYOB 299, OB/GYN directed reading tutorial, 2003
Peds/OB 282: Pregnancy, birth and infancy class. 2003-2005
Peer-Reviewed Publications
1. La Marca MJ, Westphal LM, and Rein DA. Gonadotropins and the timing of
progesterone-induced meiotic maturation of Xenopus laevis oocytes. Dev. Biol.
109:32-40, 1985.
2. Shapiro JN, Westphal LM, White PF, Sladen RN, and Rosenthal MN. Midazolam
infusion for sedation in the intensive care unit - Effect on adrenal function.
Anesthesiology, 64:394-398, 1986.
3. Doze VA, White PF, Westphal LM, and Dworsky WA. Comparison of propofol with
methohexital for outpatient anesthesia. Anesth. Analg., 65:1189-1195, 1986.
4. Westphal LM, Cheng E, White PF, Sladen RN, and Rosenthal MH. Pharmacokinetics
and pharmacodynamics of midazolam infusion following cardiac surgery.
Anesthesiology, 67:257-262, 1987.
5. El Danasouri I, Milki A, Gebhardt J, Louie D, and Westphal L. Fluorescence
staining of nuclear DNA allows for accurate assessment of the hamster egg
penetration assay. Fertil. Steril. 59:470-472,1993.
6. El Danasouri I, Westphal LM, Neev Y, Gebhardt J, Louie D, and Berns MW. Zona
opening with a 308-nm excimer laser improves fertilization by semen from
long-term vasectomized mice. Hum. Reprod. 8:464-466,1993.
7. Westphal LM, El Danasouri I, Shimizu S, Tadir Y, and Berns MW. Exposure of
human sperm to the cumulus oophorus results in increased relative force as
measured by a 760-nm laser optical trap. Hum. Reprod. 8:1083-1086,1993.
8. Simon C, Piquette GN, Frances A, Westphal LM, Heinrichs WL, and Polan ML.
Interleukin-1 type receptor messenger ribonucleic acid (mRNA) expression in
human endometrium throughout the menstrual cycle. Fertil. Steril.
59:791-796,1993.
9. El Danasouri I, Frances A, and Westphal LM. Immunocytochemical localization
of transforming growth factor-alpha and epidermal growth factor receptor in
human fallopian tubes and cumulus cells. Am. J. Reprod. Immunol. 30:82-87,1993.
10. O’Hanlan KA, and Westphal LM. First report of a vaginal foreign body
perforating into the retroperitoneum. Am. J. Obstet. Gynecol. 173:962-964,1995.
11. Milki AA, Hinckley MD, Gebhardt J, Dasig D, Westphal LM, Behr B. Accuracy of
day three criteria for selecting the best embryos? Fertil Steril.
77:1191-1195,2002.
12. Westphal, LM, Rosencrantz, M, Behr BB, and Milki AA. Significance of One
Pronucleus Prior to Fertilization. Fertil Steril: 79:1031-1033,2003.
13. Milki AA, Jun SH, Hinckley MD, Behr B, Giudice, LR, and Westphal LM.
Incidence of monozygotic twinning in blastocyst transfer compared to cleavage
stage transfer. Fertil. Steril: 79: 503-506,2003.
14. Westphal LM, Hinckley MD, Behr BR, and Milki AA. Effect of ICSI on
subsequent blastocyst development and pregnancy rates. J Assist Reprod Genet:
20:113-116,2003.
15. Milki AA, Jun SH, Hinckley MD, Westphal LM, Behr B, and Giudice LC. Does
blastocyst transfer alter the sex ratio? One program’s experience and review of
the literature. J Assist Reprod Genet:20:322-325, 2003.
16. Pang S, Kaplan B, Karande V, Westphal LM, Scott R, Givens C, and Sacks P.
Administration of Follitropin beta (Solution in cartridge) via a pen device in
women undergoing controlled ovarian hyperstimulation. Reprod Biomed Online.
7:319-26, 2003
17. Westphal LM, Polan ML, Trant AS, and Mooney SB. A nutritional supplement for
improveing fertility in women- a pilot study. J Reprod Med 49:289-93, 2004.
18. Milki AA, Hinckley M, Westphal LM, Behr B. Elective single blastocyst
transfer. Fertil Steril.:81:1697-8,2004.
19. Jensen JR, Walker JH, Milki AA, Westphal L, and Behr B. The effect of
two-hour, room temperature incubation of human spermatozoa in
TEST-Yolk buffer on the rate of fertilization in vitro. J Assist Reprod Genet
21:169-173, 2004.
20. Keye WR, Marrs RP, Check JH, Schnell V, Surrey M, Marshall DC, and EMBRACE
study group. Evaluation of mixed protocols with Bravelle (human-derived FSH) and
Repronex (hMG) to assess clinical efficacy (EMBRACE) in women undergoing in
vitro fertilization. Fertil Steril 82: 348-357, 2004.
21. Westphal LM, and Bendikson KA. Toxicology screening in ovum donors. J Assist
Reprod Genet 22:101-102, 2005.
22. Juretzka, MM, O’Hanlan KA, Katz SL, El Danasouri I and Westphal LM,. Embryo
cryopreservation after diagnosis of stage IIB endometrial cancer and subsequent
pregnancy in a gestational carrier. Fertil Steril 83:1041, 2005.
23. Nezhat CR, Littman ED, Lathi RB, Berker B, Westphal LM, Giudice LC, Milki,
AA. The dilemma of endometriosis: is consensus possible with an enigma? Fertil
Steril 84:1587-1588, 2005.
24. Henne M, Milki AA, and Westphal LM. Monochorionic triplet gestation
following in vitro fertilization using donor oocytes: case report and review of
the literature Fertil Steril 83:725-859, 2005.
25. Liou W-S, Yap, S, Chan, J, and Westphal LM. Fertility preservation in
gynecologic cancers. Fertil Steril 84:1561-1573, 2005.
26. Bendikson, K, Milki AA, Speck-Zulak A, and Westphal LM. Comparison of
antagonist cycles with and without pretreatment with oral contraceptive pills.
(Submitted to Clinical and Experimental Obstetrics and Gynecology)
27. Quintero R, Giudice LC and Westphal LM. Aromatase inhibitors in IVF
(Submitted to J Reprod Med).
28. Zhang M, Henne M, Paroski S, Kelshikar, B and Westphal LM. Obstetric
complications in oocyte recipients (In press, J Reprod Med).
29. Quintero R, Westphal LM, Lathi R, Milki AA, Giudice LC, and McCallum S.
Prevalence of sexual dysfunction in infertile women (In preparation).
30. Moayeri SE, Coutre S, Ramirez E, and Westphal LM. von Willebrand Disease
Presenting as Recurrent Hemoperitoneum Following Transvaginal Oocyte Retrieval
(Submitted to Obstetrics and Gynecology).
31. Westphal, LM, Polan ML, Trant, AS. Double-blind, placebo-controlled study of
Fertility Blend, a nutritional supplement for the optimization of fertility in
women. (Submitted to Fertility and Sterility)
32. Burney R, Gebhardt J, Behr B, Westphal LM. Normal pregnancy resulting from a
non-pronuclear oocyte at the time of examination for fertilization. (Submitted
to Fertil Steril)
33. Kea B, Gebhardt, J, Watt J, Westphal LM, Lathi R, and Behr, B. Effects of
reduced oxygen concentrations on IVF outscomes. (Submitted to Fertility and
Sterility).
Invited Articles
1. Westphal, LM. Evaluation of the infertile woman. InFocus (American
Fertility Association) Magazine, Summer 2004
2. Westphal LM. Fertility and safety of pregnancy after breast cancer. Coping
Magazine September/October, 2004.
3. Westphal LM. Fertility after breast cancer. The CBHP Report, 12:1,2005.
4. Westphal LM, Polan ML, Trant A. Impact of nutrition on fertility- natural
alternatives. Resolve patient guide.
Abstracts
1. Shapiro JM, White PF, Sladen RN, Westphal LM, Rosenthal MH. Midazolam
infusion in critically ill patients - Effect on adrenal function.
Anesthesiology, 63:A149, 1985.
2. Doze VA, Westphal LM, and White PF. Diisopropylphenol - A new intravenous
anesthetic: Comparison with methohexital for outpatient anesthesia.
Anesthesiology, 63:A206, 1985.
3. Cheng EY, Westphal LM, White PF, Sladen RN, and Rosenthal MH. Use of
midazolam infusion for sedation following aorto-coronary bypass surgery.
Anesthesiology, 65:A67, 1986.
4. El Danasouri I, and Westphal LM. Correlation between sperm morphological
characteristics and fertilization rate in vitro. American Fertility Society,
Orlando, Florida, October 1991.
5. El Danasouri I, Milki A, Gebhardt J, Louie D, Westphal LM. Fluorescence
staining of nuclear DNA facilitates accurate assessment of hamster egg
penetration. Pacific Coast Fertility Society, Indian Wells, California, April
1992.
6. Westphal LM, El Danasouri I, Shimizu S, and Berns M. Human sperm utilize
mechanical force during penetration of the cumulus mass around the oocyte.
American Fertility Society, 48th Annual Meeting, November 1992.
7. Simon C, Piquette GN, Crabtree ME, Westphal LM, Heinrichs WL, and Polan ML.
Interleukin-1 (IL-1) type I receptor expression in human endometrium during the
menstrual cycle. American Fertility Society, 48th Annual Meeting, November 1992.
8. El Danasouri I, Mauch C, Westphal LM, and Polan ML. Secretion of proteolytic
enzymes by human cumulus cells in culture. American Fertility Society, 48th
Annual Meeting, November 1992.
9. Berns MW, Tadir Y, El Danasouri I, Westphal LM, and Shimizu S. Sperm motility
studied with optical tweezers. American Society for Cell Biology, November 1992.
10. El Danasouri I, Frances A, Westphal LM, and Polan ML. Immunocytochemical
localization of transforming growth factor-alpha in the fallopian tubes and EGF-receptor
in cumulus cells. Society For Gynecologic Investigation, March 1993.
11. Simon C, El Danasouri I, Piquette G, Frances A, Westphal LM, and Polan ML.
Interleukin-1B increases its own receptor mRNA expression in cultured
decidualized human endometrial stromal cells. Society for Gynecologic
Investigation, Toronto, Canada, March 1993.
12. El Danasouri I, Frances A, and Westphal LM. Immunocytochemical localization
of collagen III and IV in human cumulus cells. Pacific Coast Fertility Society,
Indian Wells, California, April 1993.
13. El Danasouri I, Westphal LM, Neev Y, Gebhardt J, Louie D, Tadir Y, Berns MW.
Assisted fertilization of mouse oocytes using a 308-nm excimer laser to open the
zona pellucida. VIIIth World Congress on In Vitro Fertilization and Alternate
Assisted Reproduction, Kyoto, Japan, September 1993.
14. El Danasouri I, Gebhardt J, Westphal LM. Superoxide dismutase improves the
fertilization rate of mouse oocytes micromanipulated with a 308-nm excimer laser
and fertilized with low sperm concentration. VIIIth World Congress on In Vitro
Fertilization and Alternate Assisted Reproduction, Kyoto, Japan, September 1993.
15. Westphal LM, Vu, T, Pearson, S, Giudice, LC, Hoffman, AR. Insulin-like
growth factor II gene expression in uterine leiomyomata. The Endocrine Society,
Anaheim, California, June 1994.
16. Baker VL, Downey D, Shifren JL, Katz SL, Westphal LM, Nelson L, Glant M,
Jaffe RB. Reproductive endocrine effects of raloxiphene hydrochloride, a novel
selective estrogen receptor modulator, in women with a normal menstrual cycles.
Society for Gynecologic Investigation, Chicago, Illinois, March 1995.
17. Milki AA, Gebhardt J, Hinckley MD, Dasig D, Westphal LM, Behr B. How
accurate are day three criteria for the selection of the best two embryos? The
49th Annual Meeting of the Pacific Coast Reproductive Society,Rancho Mirage, CA,
April 2001.
18. Milki AA, Hinckley MD, Gebhardt J, Dasig D, Westphal LM, Behr B. Accuracy of
Day Three Criteria for Selecting the Best Embryos. American Society for
Reproductive Medicine, Orlando, Florida, October, 2001.
19. Westphal LM, Hinckley MD, Behr B, Milki AA. ICSI does not compromise
blastocyst development. The 50th Annual Meeting of the Pacific Coast
Reproductive Society, Rancho Mirage, California, April 2002.
20. Marshall DC, Surrey M, VanVoorhis B, Kenigsberg D, Check JH, McShane P,
Eisermann J, Scheiber MD, Westphal LM, Keye WR A randomized, comparative, 3-arm,
parallel group, open-label, multicenter study of the efficacy and safety of
Bravelle (purified human FSH) and Repronex(R) when mixed in the same syringe and
administered subcutaneously in continuous or sequential dose ratios to patients
(34-40 years) undergoing in-vitro fertilization: interim data. Fertil. Steril.
77 Suppl 3:S514-5,2002
21. Westphal LM, Mooney SB, Polan ML, Trant AS. Clinical study of fertility
blend, a nutritional supplement used for the optimization of reproductive health
in women. The 10th Annual Congress on Women’s Health, Hilton Head, South
Carolina, May 2002.
22. Milki AA, Jun SH, Hinckley MD, Behr B, Giudice LC, and Westphal LM.
Incidence of monozygotic twinning with blastocyst transfer compared to cleavage
stage transfer. American Society for Reproductive Medicine, Seattle, Washington,
October 2002.
23. Milki AA, Jun SH, Hinckley MD, Westphal LM, Behr B, and Giudice LC. Does
blastocyst transfer alter the sex ratio? One program’s experience and review of
the literature. American Society for Reproductive Medicine, Seattle, Washington,
October 2002.
24., Keye WR, Surrey M, VanVoorhis B, Kenigsberg D, Check JH, McShane P,
Eisermann J, Scheiber MD, Westphal LM, Marshall DC. A randomized, comparative,
3-arm, parallel group, open-label, multicenter study of the efficacy and safety
of Bravelle (purified human FSH) and Repronex when mixed in the same syringe and
administered subcutaneously in continuous or sequential dose ratios to patients
(34-40 years) undergoing fertilization: final data. Pacific Coast Reproductive
Society, Rancho Mirage, California, April 2003.
25. Pang S, Kaplan B, Karande V, Westphal LM, Scott R, Givens C, Sacks P (The
Follistim Pen™ COH Study Group). Self-administration of Follistim® aq in women
undergoing controlled ovarian hyperstimulation (coh): ease of use, safety, and
efficacy of the follistim™ pen. Pacific Coast Reproductive Society, Rancho
Mirage, California, April 2003.
26. Bendikson KA and Westphal LM. Accuracy of drug use self reporting in oocyte
donors.. Pacific Coast Reproductive Society, Rancho Mirage, California, April
2003.
27. Rugo H, Westphal LM, and Berlin L Combining Patient and Research Priorities:
Lessons Learned in a Community Research Collaboration Design of a Clinical Trial
8AB-1701. Received Honorable Mention, California Breast Cancer Research Program
Symposium, San Diego, California, September 2003.
28. Berlin L, Westphal LM, Rugo H, Xing F, and Heckmann J. What Do Young
Patients Want to Know about the Ovarian Toxicity of Chemotherapy? Received
Honorable Mention, California Breast Cancer Research Program Symposium, San
Diego, California, September 2003.
29. Speck-Zulak A, Lathi R, Fuhrel A, Westphal LM, and Milki AA. Comparison of
Multi-Dose Versus Individual Ampules of Gonal-F for IVF. American Society of
Reproductive Medicine, San Antonio, Texas, October 2003.
30. Littman E, Lathi R, Westphal LM, Milki AA. Antagon vs. flare: examining the
effect of IVF protocols in a population of poor responders. American Society of
Reproductive Medicine, San Antonio, Texas, October 2003.
31. Bendikson K, Milki AA, Speck-Zulak, A, and Westphal LM. Comparison of GnRH
antagonist cycles with and without oral contraceptive pill pretreatment in poor
responders. American Society of Reproductive Medicine, San Antonio, Texas,
October 2003.
32. Milki AA, Littman E, Hinckley M, Westphal LM, Gebhardt J, Behr B. Elective
single blastocyst transfer. American Society of Reproductive Medicine, San
Antonio, Texas, October 2003.
33. Westphal, LM, Polan ML, and Trant A. Nutritional supplement improves
fertility in women- a pilot study. APHA meeting, San Francisco, California,
November 2003.
34. Kao LC, Westphal LM, Giudice LC. Global expression comparisons of human
endometrium between normal individuals and hyperstimulated donors. Society for
Gynecologic Investigation, Houston, Texas, March 2004.
35. Henne M, Milki AA, and Westphal LM. Monochorionic triplet gestation
following in vitro fertilization using donor oocytes: case report. Pacific Coast
Reproductive Society, Rancho Mirage, California, April, 2004.
36. Lathi R, Mark SD, Westphal LM, and Milki AA. Utility of cytogenetic testing
of missed abortions in absence of fetal pole on ultrasound. Pacific Coast
Reproductive Society, Rancho Mirage, California, April, 2004
37. Quintero R, Giudice LC, and Westphal LM. Efficacy of aromatase inhibitors in
poor responders undergoing in vitro fertilization. Pacific Coast Reproductive
Society, Rancho Mirage, California, April, 2004
38. Henne M, Kelshikar B, Behera M, Zhang M, Paroski S, Lathi R, Westphal LM,
Obstetric complications in recipients of donated oocytes. 18th World Congress on
Fertility and Sterility, Montreal, Canada, May 2004.
39. Milki AA, Hinckley M,Lathi R, Westphal LM, and Behr B. Elective Single
Blastocyst Transfer: cumulative
outcomes from the fresh and subsequent frozen cycles. American Society for
Reproductive Medicine, Philadelphia, Pennsylvania, October 2004.
40. Quintero R, Westphal LM, Lathi R, Milki AA, Giudice LC, and McCallum S.
Incidence of female sexual dysfunction in an infertile population. 11th World
Congress of the International Society for Sexual and Impotence Research, Buenos
Aires, Argentina, October, 2004.
41. Henne MB, Krieg S, Westphal LM. Matched comparison of obstetric outcomes in
recipients of donor oocytes versus IVF controls. Pacific Coast Reproductive
Society, Rancho Mirage, California, May 2005.
42. Quintero RB, Westphal LM, Lathi RB, Milki AA, Giudice LC, and McCallum SW.
Prevalence of erectile dysfunction in an infertile population. Pacific Coast
Reproductive Society, Rancho Mirage, California, May 2005.
43. Kea B, Gebhardt J, Westphal L, Lathi R, Watt J, and Behr B. Effects of
reduced oxygen concentrations on IVF outcome. Pacific Coast Reproductive
Society, Rancho Mirage, California, May 2005.
44. Berlin L, Westphal LM, and Rugo H. Which chemo and when? Young women’s
perspective and needs after diagnosis. National Breast Cancer Coalition Fund (NBCCF),
Washington DC, May 2005.
45. Rugo H, Bruckner J, Westphal L, and Berlin L. Effect of GnRH Therapy during
Adjuvant Chemotherapy on Ovarian Function in Older Premenopausal Women with
Breast Cancer: A Community Collaborative Research Grant from the California
Breast Cancer Research Program. California Breast Cancer Research Program
Symposium, Sacramento, California, September 2005.
46 Berlin L, Rugo H, and Westphal L. Listening to young survivors: impact of
ovary toxic chemotherapy and interest in ovary sparing chemotherapy. California
Breast Cancer Research Program Symposium, Sacramento, California, September
2005.
47. Moayeri SE, Behr B, Lathi RB, Westphal LM, Giudice LC, and Milki AA. Does
the incidence of monozygotic twinning with blastocyst transfer decrease with
time? American Society for Reproductive Medicine, Montreal, Canada, October
2005.
48. Burney RO, Moayeri SE, Milki AA, Westphal LM, and Lathi RB. The prevalence
and severity of intrauterine adhesions in an infertile population undergoing
office hysteroscopy. American Society for Reproductive Medicine, Montreal,
Canada, October 2005.
49. Moayeri SE, Burney RO, Milki AA, Westphal LM, Behr B, and Lathi RB.
Pregnancy loss and aneuploidy rate in fresh versus frozen blastocyst transfer.
American Society for Reproductive Medicine, Montreal, Canada, October 2005.
50. Quintero RB, Helmer A, Murray E, and Westphal LM. Fertility preservation in
female cancer patients. American Society for Reproductive Medicine, Montreal,
Canada, October 2005.
51. Moayeri SE, Coutre S, Ramirez E, and Westphal LM. von Willebrand disease
presenting as recurrent hemoperitoneum following transvaginal oocyte retrieval.
American Society for Reproductive Medicine, Montreal, Canada, October 2005.
52. Berlin LM, Westphal LM, and Rugo HS. Neoadjuvant vs. adjuvant chemotherapy:
young women’s experiences, attitudes and information needs after diagnosis. San
Antonio Breast Cancer Symposium, San Antonio, Texas, December 2005.
53. McLaren, J, Burney RO, Dahan MH, Milki AA, Westphal LM, and Lathi RB. Effect
of methotrexate on subsequent fertility in patients undergoing ART. Pacific
Coast Reproductive Society, Rancho Mirage, California, April 2006.
Book Chapters
1. Westphal LM and SB Mooney. Conscious Sedation for Assisted Reproductive
Technologies. In: Conscious Sedation. ed. Jeanine P. Wiener-Kronish and Michael
A. Gropper. Hanley & Belfus, Inc., Philadelphia, 2001.
2. Chen B, Littman ED, Milki AA, and Westphal LM. Gynecology/Infertility Surgery
In: Anesthesiologist’s Manual of Surgical Procedures. ed. Jaffe RA and Samuels
SI, Lipincott Williams and Wilkins, Philadelphia, 2004.
3. Westphal LM, Tazuke SI, Chen B, Giudice LC. Disorders of the endometrium:
Abnormal uterine bleeding, endometriosis, adenomyosis and implantation.
In:Infertil Clinics of North America, 236-248, 2003.
4. Westphal, LM and Moayeri, S. Radiation and chemotherapy for cancer; effects
on the uterus in The Endometrium (in preparation).
Other Activities
Moderator, 49th Annual Meeting of the Pacific Coast Reproductive Society,
April 2001. Rancho Mirage, CA.
Advisory Board for Fertile Hope, a nonprofit organization to promote fertility
preservation in cancer patients.
Poster Awards Committee, American Society for Reproductive Medicine, San
Antonio, Texas, October 2003.
Scientific Chair, “Ovum Donation and Beyond: Frontiers in Medicine,” New York,
December 2003.
Contributor to “Women Doctors Guide to Health and Healing” Published by Oxmoor
House, 2003.
Contributor to “Young For Life.” Published by Oxmoor House, 2004.
Media
Bay Area Reporter, 1995. Dr. Westphal interviewed about safety of donor
insemination.
Local News Channels 7, 5, 4 and 2: 2/8/2000, Controversy about the $100,000 egg
donor add in the Stanford Daily. Dr. Westphal interviewed and quoted.
San Jose Mercury News 2/11/2000: Controversy over egg donor ad. Dr. Westphal
interviewed and quoted.
Stanford Report, February 23, 2000: “Cancer patients may preserve fertility
through egg-freezing program”. Dr. Westphal interviewed and quoted.
The Learning Channel, NYT Television: “Maternity Ward”, episode #2: Hard Labor”.
Dr. Westphal interviewed, quoted and featured, 2000.
Stanford Medicine Magazine, Fall, 2000, Vol 17, No. 3: "Preserving fertility
through egg-freezing". Dr. Westphal interviewed and quoted.
Stanford Magazine, November/December, 2000: "What are the costs?" Dr. Westphal
featured, interviewed and quoted about oocyte donation.
USA Today Magazine, February 2001: "Freezing Eggs of Cancer Patients." Dr.
Westphal quoted.
Redefined Woman Magazine, June 2001. Dr. Westphal interviewed and quoted about
oocyte cryopreservation in oncology patients.
New York Times, November 13, 2001. Dr. Westphal interviewed and quoted about
fertility options for cancer patients.
Good Morning America (ABC), February 27, 2002. Dr. Westphal interviewed about
oocyte cryopreservation for cancer patients. This nationally televised program
was followed by a live webchat with Dr. Westphal.
Glamour Magazine, March 2002. Dr. Westphal quoted about fertility options for a
cancer patient.
Boston Globe, March 8, 2002. Dr.Westphal interviewed about uterine
transplantation.
Oakland Tribune, May 12, 2002. Dr. Westphal interviewed about oocyte donation.
Mornings on Two (KTVU), May 16, 2002. Dr. Westphal interviewed about nutrition
supplement and fertility.
Arkansas Democrat Gazette, July 8, 2002. Dr. Westphal interviewed about
fertility issues.
BBC, August 3, 2002. Dr. Westphal interviewed about preimplantation genetic
diagnosis.
Natural Health Magazine, December 2002. Dr. Westphal interviewed about fertility
and nutritional supplements.
KRON-TV, December 18,2002. Dr. Westphal interviewed about preventing Down’s
Syndrome.
Healthology, February 11,2003. Dr. Westphal interviewed about fertility
preservation for cancer patients.
Stanford Medicine Magazine, Winter 2003, Vol 20, No. 1: “Frozen Assets.” Dr.
Westphal interviewed and quoted about oocyte and embryo cryopreservation.
Parenting Magazine, May 2003. Dr. Westphal interviewed about pregnancy issues.
San Mateo County Times, July 18, 2003. Dr. Westphal interviewed about fertility
options.
Tech TV, August 8, 2003. Dr. Westphal interviewed about uterine transplants.
Cosmopolitan Magazine, September 2003. “Bumps below the belt” advice by Dr.
Westphal
San Francisco Magazine, October 2003. Dr. Westphal profiled in article about
fertility preservation.
Shape Magazine, November 2003. Dr. Westphal asked about ovum donation.
Tennessean, February 10, 2004. Dr. Westphal discussed nutritional supplements.
KTVU (Fox) February 27, 2004. Dr. Westphal interviewed about egg freezing.
Fox News (multiple stations), March 18, 2004. Dr. Westphal interviewed about egg
freezing.
Good Morning America (ABC), March 22, 2004. Dr. Westphal discussed egg freezing
procedure.
Elle Magazine, April 2004. Dr. Westphal interviewed about fertility and egg
freezing.
San Jose Mercury News, April 13, 2004. Dr. Westphal interviewed about fertility
testing.
KGO radio, April 19, 2004. Dr. Westphal interviewed about fertility and
nutritional supplements.
Reuters Health May 14, 2004. Dr. Westphal discussed study on nutritional
supplements.
Chicago Tribune, June 20, 2004. Dr. Westphal interviewed about egg freezing.
KGO radio, June 29, 2004. Dr. Westphal interviewed about pregnancy after ovarian
transplant.
Philadelphia Inquirer, August 1, 2004. Dr. Westphal interviewed about egg
freezing.
Orange county Registrar, September 18, 2004. Dr. Westphal interviewed about
fertility options for cancer patients.
Self Magazine, October 2004. Dr. Westphal interviewed about fertility after
breast cancer treatment.
ABC News Now. Dr. Westphal interviewed about nutritional supplements.
Readers Digest Medical Breakthroughs 2004. Dr. Westphal interviewed about
nutritional supplements and fertility
Cosmopolitan magazine, January 2005. Dr. Westphal discussed egg freezing.
Pacific Sun, January 19,2005. Dr. Westphal discussed egg freezing.
Conceive magazine, Summer 2005. Dr. Westphal discusses nutritional supplement
and fertility.
NBC 11 News, May 3, 2005. Dr. Westphal interviewed about nutritional
supplements.
Elle Magazine, July 2005. Dr. Westphal interviewed about fertility and
alternative treatments.
WebMD, July 2005. Dr. Westphal interviewed about nutritional supplements and
fertility.
MAMM magazine, July/August 2005. Dr. Westphal interviewed about fertility
preservation for cancer survivors.
San Jose Mercury News, August 22, 2005. Dr. Westphal interviewed about a
nutritional supplement.
ABC7 news, October 28, 2005. Dr. Westphal interviewed about Fertile Hope and
fertility preservation.
